Research Partnership

At Research Partnership, we pride ourselves on delivering insights that are not only comprehensive but also presented in a way that drives meaningful discussions. We’re honored to share this feedback from a Market Research Lead. We’re grateful for the opportunity to collaborate with such amazing partners and look forward to many more engaging discussions ahead. Interested in learning how we can hep for your organization? Let's connect and explore the possibilities: https://lnkd.in/eqHtvJZu #MarketResearch #ClientSuccess #Insights #HealthcareResearch #ResearchPartnership

We are pleased to announce the readout of the first report covering Alzheimer’s disease from Therapy Watch, our syndicated market tracking solution. This report offers comprehensive analysis and critical data to support healthcare professionals and stakeholders in their efforts to combat this disease. This resource is essential for anyone involved in the Alzheimer's Disease space, from pharmaceutical companies to healthcare providers, offering the latest insights and forecasts to inform strategic decisions. Learn more here: https://lnkd.in/e6rQpAyz #AlzheimersDisease #HealthcareResearch #MarketAnalysis #HealthcareInsights #Pharmaceuticals #HealthcareInnovation

We’re excited to be headed to #ESMO24 on September 13 – 17 in Fira, Barcelona. We will also be joined by our colleagues across Inizio. Stop by booth 431e to exchange insights that can help shape the future of oncology treatments. Visit the ESMO website to register for the conference and to see the rest of the program. #ESMO24 #Oncology #Oncology #CancerResearch #OncologyTreatments

At Research Partnership, we're dedicated to uncovering critical insights that drive better healthcare outcomes. Our latest case study delves into healthcare professionals' perceptions of the impact of Major Depressive Disorder (MDD) with Clinically Relevant Insomnia Symptoms (CRIS) on patients' quality of life. Discover how our team used innovative methodologies to provide actionable insights that can help improve patient care and support healthcare professionals in their decision-making. Read the case study here: https://lnkd.in/eKwdjX5b #HealthcareResearch #MDD #Insomnia #PatientCare #QualityOfLife

As Artificial Intelligence continues to transform the healthcare landscape, it’s crucial to address the challenges that come with it—especially the risk of replicating social biases in synthetic patient data. In our latest insight, which was published in Pharmafocus, we explore how human intelligence, when partnered with AI, can mitigate these risks and ensure that the data used in healthcare is both accurate and equitable. Discover how Research Partnership is at the forefront of combining human expertise with cutting-edge AI to drive better, bias-free healthcare solutions here: https://lnkd.in/eZQzvTjx #ArtificialIntelligence #HealthcareAI #SyntheticData #SocialBias #HealthcareEthics #HealthcareInsights

We had a few of our experts attend the EphMRA Conference in London this year. With over 200 delegates from 70 different companies, there were a lot of insights to learn and share. Wondering what the key takeaways were? See our latest insight to learn more: https://lnkd.in/dXCHC7Tr #EphMRA #EphMRA2024 #MarketResearch #BusinessIntelligence #Pharma #Pharmaceuticals #Healthcare #HealthEquity

We are excited to announce that two of our abstracts have been accepted for poster presentations at UEG Week, Vienna. If you are attending the event from October 12-15, keep a lookout for our abstract titles: - To what extent are physicians cycling through more than one TNFI (tumor necrosis factor inhibitor) in ulcerative colitis (UC) treatment? - What is the profile of Crohn’s disease patients who are in the 3rd or 4th line of advanced treatment? Both abstracts are taken from our syndicated IBD Therapy Watch patient chart audit tracking study. Learn more here: https://lnkd.in/erCFDnTW #UEGWeek #Abstracts #Presentations #Physicians #Treatment #Syndicated #TherapyWatch

We're excited to share our insights from the Pharma Market Research Conference PMRC in San Francisco! The conference provided a wealth of knowledge and innovative perspectives on the current trends and future directions in healthcare market research. Read our latest insight to see what we learned: https://lnkd.in/e6FAbYSD #PMRC #MarketResearch #AI #Pharma #Pharma #Healthcare

We are thrilled to announce that Bilal B. has joined Research Partnership as our newest Analytics Director. Bilal brings a over 10 years of experience and expertise as a statistician, working on numerous Demand assessment studies, Message testing studies, Brand tracking studies, Patient journey studies and many more. We are excited to see the incredible contributions he will make to our team. Join us in giving Bilal a warm welcome and wishing him all the success in his new role. We look forward to achieving great things together! Learn more about Bilal here: https://lnkd.in/e-Knb2J4 #Welcome #NewTeamMember #MeetOurTeam #TeamExpansion

Good news for NewAmsterdam Pharma Corporation, who have announced the latest positive results for obicetrapib in heterozygous familial hypercholesterolemia (heFH). #TherapyWatch, Research Partnership’s syndicated research division, has been monitoring the use of lipid-lowering treatments in heFH since 2018, in various markets across Europe, Asia and Canada. For more information, visit: https://lnkd.in/enMKnZai